Related references
Note: Only part of the references are listed.In Vitro and In Vivo Studies of the Antiparasitic Activity of Sterol 14α-Demethylase (CYP51) Inhibitor VNI against Drug-Resistant Strains of Trypanosoma cruzi
Maria de Nazare Correia Soeiro et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Whole-organism high-throughput screening against Trypanosoma brucei brucei
Amy J. Jones et al.
EXPERT OPINION ON DRUG DISCOVERY (2013)
Approaches to Protozoan Drug Discovery: Phenotypic Screening
Melissa L. Sykes et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
Examination of the Mode of Action of the Almiramide Family of Natural Products against the Kinetoplastid Parasite Trypanosoma brucei
Laura M. Sanchez et al.
JOURNAL OF NATURAL PRODUCTS (2013)
Marine natural products
John W. Blunt et al.
NATURAL PRODUCT REPORTS (2013)
Iotrochamides A and B, antitrypanosomal compounds from the Australian marine sponge Iotrochota sp.
Yunjiang Feng et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2012)
Lessons from the Past and Charting the Future of Marine Natural Products Drug Discovery and Chemical Biology
William H. Gerwick et al.
CHEMISTRY & BIOLOGY (2012)
Chronic Chagas' heart disease: a disease on its way to becoming a worldwide health problem: epidemiology, etiopathology, treatment, pathogenesis and laboratory medicine
Silvia Gilka Munoz-Saravia et al.
HEART FAILURE REVIEWS (2012)
Safety of benznidazole use in the treatment of chronic Chagas' disease
Alejandro M. Hasslocher-Moreno et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2012)
Natural Products As Sources of New Drugs over the 30 Years from 1981 to 2010
David J. Newman et al.
JOURNAL OF NATURAL PRODUCTS (2012)
Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010
Christopher J. L. Murray et al.
LANCET (2012)
Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010
Rafael Lozano et al.
LANCET (2012)
Antitrypanosomal Alkaloids from the Marine Bacterium Bacillus pumilus
Sergio Martinez-Luis et al.
MOLECULES (2012)
Survey of n-3 and n-6 polyunsaturated fatty acids in fish and fish products
Claudia Strobel et al.
LIPIDS IN HEALTH AND DISEASE (2012)
Manadoperoxides, a new class of potent antitrypanosomal agents of marine origin
Giuseppina Chianese et al.
ORGANIC & BIOMOLECULAR CHEMISTRY (2012)
Identification of Compounds with Anti-Proliferative Activity against Trypanosoma brucei brucei Strain 427 by a Whole Cell Viability Based HTS Campaign
Melissa L. Sykes et al.
PLOS NEGLECTED TROPICAL DISEASES (2012)
Diverse Inhibitor Chemotypes Targeting Trypanosoma cruzi CYP51
Shamila S. Gunatilleke et al.
PLOS NEGLECTED TROPICAL DISEASES (2012)
Antitrypanosomal Activity of Fexinidazole, a New Oral Nitroimidazole Drug Candidate for Treatment of Sleeping Sickness
Marcel Kaiser et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Convolutamines I and J, antitrypanosomal alkaloids from the bryozoan Amathia tortusa
Rohan A. Davis et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2011)
The Uniqueness of the Trypanosoma cruzi Mitochondrion: Opportunities to Target New Drugs Against Chagas Disease
Lisvane Silva Paes et al.
CURRENT PHARMACEUTICAL DESIGN (2011)
State of the Art in African Trypanosome Drug Discovery
Robert T. Jacobs et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2011)
Antimalarial β-Carbolines from the New Zealand Ascidian Pseudodistoma opacum
Susanna T. S. Chan et al.
JOURNAL OF NATURAL PRODUCTS (2011)
New Tetromycin Derivatives with Anti-Trypanosomal and Protease Inhibitory Activities
Sheila M. Pimentel-Elardo et al.
MARINE DRUGS (2011)
Cytarabine Dose for Acute Myeloid Leukemia
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Acanthifoliosides, minor steroidal saponins from the Caribbean sponge Pandaros acanthifolium
Erik L. Regalado et al.
TETRAHEDRON (2011)
Synthesis of Marine-Derived 3-Alkylpyridinium Alkaloids with Potent Antiprotozoal Activity
Boris Rodenko et al.
ACS MEDICINAL CHEMISTRY LETTERS (2011)
The Human African Trypanosomiasis Control and Surveillance Programme of the World Health Organization 2000-2009: The Way Forward
Pere P. Simarro et al.
PLOS NEGLECTED TROPICAL DISEASES (2011)
SCYX-7158, an Orally-Active Benzoxaborole for the Treatment of Stage 2 Human African Trypanosomiasis
Robert T. Jacobs et al.
PLOS NEGLECTED TROPICAL DISEASES (2011)
Identification of a κ-opioid agonist as a potent and selective lead for drug development against human African trypanosomiasis
Deuan C. Jones et al.
BIOCHEMICAL PHARMACOLOGY (2010)
Assessing the trypanocidal potential of natural and semi-synthetic diketopiperazines from two deep water marine-derived fungi
Katharine R. Watts et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2010)
Tolerance and Safety of Nifurtimox in Patients with Chronic Chagas Disease
Yves Jackson et al.
CLINICAL INFECTIOUS DISEASES (2010)
Recent Insights into the Biosynthesis and Biological Activities of Natural Xanthones
H. R. El-Seedi et al.
CURRENT MEDICINAL CHEMISTRY (2010)
Effects of the calpain inhibitor MDL28170 on the clinically relevant forms of Trypanosoma cruzi in vitro
Vitor Ennes-Vidal et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2010)
Manadoperoxides A-D from the Indonesian Sponge Plakortis cfr. simplex. Further Insights on the Structure-Activity Relationships of Simple 1,2-Dioxane Antimalarials
Caterina Fattorusso et al.
JOURNAL OF NATURAL PRODUCTS (2010)
Antitrypanosomal Cyclic Polyketide Peroxides from the Australian Marine Sponge Plakortis sp.
Yunjiang Feng et al.
JOURNAL OF NATURAL PRODUCTS (2010)
Antiprotozoal Steroidal Saponins from the Marine Sponge Pandaros acanthifolium
Erik L. Regalado et al.
JOURNAL OF NATURAL PRODUCTS (2010)
Bromopyrrole Alkaloids as Lead Compounds against Protozoan Parasites
Fernando Scala et al.
MARINE DRUGS (2010)
Inhibitory Activity of Marine Sponge-Derived Natural Products against Parasitic Protozoa
Ilkay Orhan et al.
MARINE DRUGS (2010)
The promise of T-cruzi genomics
Julie Clayton
NATURE (2010)
Chagas disease: pushing through the pipeline
Julie Clayton
NATURE (2010)
N-myristoyltransferase inhibitors as new leads to treat sleeping sickness
Julie A. Frearson et al.
NATURE (2010)
In vitro and in vivo experimental models for drug screening and development for Chagas disease
Alvaro Jose Romanha et al.
MEMORIAS DO INSTITUTO OSWALDO CRUZ (2010)
Antitrypanosomal pyridoacridine alkaloids from the Australian ascidian Polysyncraton echinatum
Yunjiang Feng et al.
TETRAHEDRON LETTERS (2010)
Current and developing therapeutic agents in the treatment of Chagas disease
Werner Apt
DRUG DESIGN DEVELOPMENT AND THERAPY (2010)
Structural Characterization of CYP51 from Trypanosoma cruzi and Trypanosoma brucei Bound to the Antifungal Drugs Posaconazole and Fluconazole
Chiung-Kuang Chen et al.
PLOS NEGLECTED TROPICAL DISEASES (2010)
Antiprotozoal Activity of 1-Phenethyl-4-Aminopiperidine Derivatives
Christophe Dardonville et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Novel S-Adenosylmethionine Decarboxylase Inhibitors for the Treatment of Human African Trypanosomiasis
Robert H. Barker et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Trypanocidal Activity of 8-Methyl-5′-{[(Z)-4-Aminobut-2-enyl](Methylamino)}Adenosine (Genz-644131), an Adenosylmethionine Decarboxylase Inhibitor
Cyrus J. Bacchi et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Isoquinoline-based analogs of the cancer drug clinical candidate tipifarnib as anti-Trypanosoma cruzi agents
Naveen Kumar Chennamaneni et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2009)
Trypanosoma cruzi targets for new chemotherapeutic approaches
Maria Nazare C. Soeiro et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2009)
Nifurtimox-eflornithine combination therapy for second-stage African Trypanosoma brucei gambiense trypanosomiasis: a multicentre, randomised, phase III, non-inferiority trial
Gerardo Priotto et al.
LANCET (2009)
Dissecting the essentiality of the bifunctional trypanothione synthetase-amidase in Trypanosoma brucei using chemical and genetic methods
Susan Wyllie et al.
MOLECULAR MICROBIOLOGY (2009)
Screening of Agelasine D and Analogs for Inhibitory Activity against Pathogenic Protozoa; Identification of Hits for Visceral Leishmaniasis and Chagas Disease
Anders Vik et al.
MOLECULES (2009)
Current epidemiological trends for Chagas disease in Latin America and future challenges in epidemiology, surveillance and health policy
Alvaro Moncayo et al.
MEMORIAS DO INSTITUTO OSWALDO CRUZ (2009)
Isolation of Aerucyclamides C and D and Structure Revision of Microcyclamide 7806A: Heterocyclic Ribosomal Peptides from Microcystis aeruginosa PCC 7806 and Their Antiparasite Evaluation
Cyril Portmann et al.
JOURNAL OF NATURAL PRODUCTS (2008)
Antiprotozoal activities of heterocyclic-substituted xanthones from the marine-derived fungus Chaetomium sp.
Alexander Pontius et al.
JOURNAL OF NATURAL PRODUCTS (2008)
Antiparasitic, antineuroinflammatory, and cytotoxic polyketides from the marine sponge Plakortis angulospiculatus collected in Brazil
Miriam H. Kossuga et al.
JOURNAL OF NATURAL PRODUCTS (2008)
Nifurtimox-Eflornithine combination therapy for second-stage Trypanosoma brucei gambiense sleeping sickness:: A randomized clinical trial in Congo
Gerardo Priotto et al.
CLINICAL INFECTIOUS DISEASES (2007)
Marine natural products from the Turkish sponge Agelas oroides that inhibit the enoyl reductases from Plasmodium falciparum, Mycobacterium tuberculosis and Escherichia coli
Deniz Tasdemir et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2007)
Replication and homologous recombination repair regulate DNA double-strand break formation by the antitumor alkylator ecteinascidin 743
Daniele Grazziotin Soares et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Venturamides A and B:: Antimalarial constituents of the Panamanian marine cyanobacterium Oscillatoria sp.
Roger G. Linington et al.
JOURNAL OF NATURAL PRODUCTS (2007)
Comparison of the activities of the truncated halichondrin B analog NSC 707389 (E7389) with those of the parent compound and a proposed binding site on tubulin
Donnette A. Dabydeen et al.
MOLECULAR PHARMACOLOGY (2006)
Innovative lead discovery strategies for tropical diseases
Solomon Nwaka et al.
NATURE REVIEWS DRUG DISCOVERY (2006)
Mechanisms for the hypotriglyceridemic effect of marine omega-3 fatty acids
Michael H. Davidson
AMERICAN JOURNAL OF CARDIOLOGY (2006)
Cross-talk between nucleotide excision and homologous recombination DNA repair pathways in the mechanism of action of antitumor trabectedin
Ana B. Herrero et al.
CANCER RESEARCH (2006)
Novel bioactive bromopyrrole alkaloids from the Mediterranean sponge Axinella verrucosa
A Aiello et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2006)
The primary antimitotic mechanism of action of the synthetic halichondrin E7389 is suppression of microtubule growth
MA Jordan et al.
MOLECULAR CANCER THERAPEUTICS (2005)
Opportunities and challenges in antiparasitic drug discovery
R Pink et al.
NATURE REVIEWS DRUG DISCOVERY (2005)
Induction of morphological and biochemical apoptosis following prolonged mitotic blockage by halichondrin B macrocyclic ketone analog E7389
G Kuznetsov et al.
CANCER RESEARCH (2004)
Ziconotide: Neuronal calcium channel blocker for treating severe chronic pain
GP Miljanich
CURRENT MEDICINAL CHEMISTRY (2004)
Viscosamine: The first naturally occurring trimeric 3-alkyl pyridiniurn alkaloid
CA Volk et al.
ORGANIC LETTERS (2003)
cAC10-vcMMAE, an anti-CD30-monomethyl auristatin E conjugate with potent and selective antitumor activity
JA Francisco et al.
BLOOD (2003)
Myristoyl-CoA:protein N-myristoyltransferase, an essential enzyme and potential drug target in kinetoplastid parasites
HP Price et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Lepadins D-F:: Antiplasmodial and antitrypanosomal decahydroquinoline derivatives from the tropical marine tunicate Didemnum sp.
AD Wright et al.
JOURNAL OF MEDICINAL CHEMISTRY (2002)
Antiproliferative activity of ecteinascidin 743 is dependent upon transcription-coupled nucleotide-excision repair
Y Takebayashi et al.
NATURE MEDICINE (2001)
Differential rates of reversibility of ecteinascidin 743-DNA covalent adducts from different sequences lead to migration to favored bonding sites
M Zewail-Foote et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2001)
Glycolysis as a target for the design of new anti-trypanosome drugs
CLM Verlinde et al.
DRUG RESISTANCE UPDATES (2001)
Tryptophol, a plant auxin isolated from the marine sponge Ircinia spinulosa
I Erdogan et al.
BIOCHEMICAL SYSTEMATICS AND ECOLOGY (2000)
A new bioactive sesterterpene and antiplasmodial alkaloids from the marine sponge Hyrtios cf. erecta
G Kirsch et al.
JOURNAL OF NATURAL PRODUCTS (2000)
Share Paper
